PQA Pharmaceutical Joint Stock Company
PQA Pharmaceutical Joint Stock Company
🇻🇳 Vietnam, Ninh Binh
201111-50 peopleManufacturer/Distributor/Wholesaler/Trading CompanyPQA Pharmaceutical Joint Stock Company is a Vietnam-based manufacturer and distributor specializing in traditional medicine and herbal supplements. Established in 2011 and headquartered in Ninh Binh, the company operates a manufacturing facility that adheres to GMP-WHO and GLP standards. PQA focuses on the research and production of Eastern and Southern traditional medicines, offering a diverse portfolio that includes treatments for asthma, respiratory issues, digestive health, musculoskeletal disorders, and sinusitis. Their product range also extends to dietary supplements, cosmetics, medical devices, and hygiene products. As an OEM service provider, the company leverages its dedicated research center (Trung tâm nghiên cứu thuốc YHCT PQA) to develop high-quality herbal formulations. PQA maintains a strong distribution network, cooperating with numerous major hospitals and organizations across Vietnam, including specialized pediatric and maternity hospitals. With a workforce of approximately 11 to 50 employees, the company is recognized for its commitment to quality and its integration of traditional medicinal practices with modern manufacturing excellence.
OEM manufacturerOffers OEM services for customized brand manufacturing.
Own brandOwns and operates its own brands and manufacturing facilities.
High-tech enterpriseRecognized as a high-tech or innovative enterprise.
Contact
********************
1
***********
1
Products
PQA THƯ CAN DƯỠNG HUYẾT 250ML
PQA XƯƠNG KHỚP* (viên nang)
PQA XUYÊN KHUNG XƯƠNG KHỚP
PQA THẬP TOÀN ĐẠI BỔ
PQA ÍCH KHÍ THĂNG DƯƠNG
PQA THƯ GIÃN GÂN CƠ (Viên nang)
PQA THƯ CÂN (viên nang)
PQA KIỆN TỲ ÍCH KHÍ (125ml)
PQA HOÀNG KỲ VIÊN NANG
PQA Kiện Tỳ Ích Khí 250ml
THUỐC PQA VIÊM MŨI DỊ ỨNG
THUỐC PQA VIÊM AMIDAN (dạng ống)
Customers
BENH VIEN NHI HAI DUONG
1
*******************************
****************************
***************************
***************************
Unlock all 6 customers
Certifications
GMP1
Ask AI about this supplier
Factory images
Shipments
Shipments count
0
Export volume
0 kg
Export countries
0
Insights
Top 5 customers
Reflecting the depth of cooperation between supplier and customersTop 5 customers
This insight is only available in the Pro planTop 5 export countries
Reflecting the supplier's export experience in target countriesTop 5 export countries
This insight is only available in the Pro planShipment count distribution
Reflecting the supplier's market business activityAll categories
Shipment count distribution
This insight is only available in the Pro planExport weight distribution (kg)
Reflecting the supplier's export scaleAll categories
Export weight distribution (kg)
This insight is only available in the Pro planExport weight trend (kg)
Reflecting the growth rate of the supplier's phased total supply volume and the fluctuation of supply volume, identifying supply peaks and troughsAll categories
Export weight trend (kg)
This insight is only available in the Pro planCIF trend (USD)
For identifying high-value cooperation periods and single order value changesAll categories
CIF trend (USD)
This insight is only available in the Pro planSimilar suppliers you may like
Ha Tay Pharmaceutical Joint Stock Company
🇻🇳 Vietnam
1965501-1000 peopleManufacturer/Trading Company/Wholesaler/Distributor/Service CompanyHigh capacity factory
Established brand
OEM manufacturer
Own brand
Shipments
2
Key customer
CANOPUS
Key market
🇻🇳 Vietnam
Description
Ha Tay Pharmaceutical Joint Stock Company (Hataphar), established in 1965 and headquartered in Hanoi, is a premier pharmaceutical manufacturer and distributor in Vietnam. Consistently ranked among the top 10 pharmaceutical enterprises in the country, the company operates as a publicly traded entity on the Hanoi Stock Exchange (HNX: DHT). With a workforce of over 780 employees, Hataphar specializes in the production, import, export, and distribution of a wide range of pharmaceutical products, including medicines, functional foods, cosmetics, medical equipment, and vaccines.
The company maintains a robust manufacturing infrastructure comprising three major facilities: a 17,000 sqm pharmaceutical factory, a 2,000 sqm supplement factory, and the advanced 45,000 sqm Hataphar High-Tech Pharmaceutical Factory. Demonstrating a commitment to international quality standards, Hataphar holds certifications for GMP-WHO, GLP, GSP, GDP, and GPP. Notably, through a strategic partnership with ASKA Pharmaceutical (Japan), the company has implemented PIC/s/Japan-GMP standards and is developing facilities to meet EU-GMP requirements for hormone-containing drugs and other specialized preparations.
Beyond its core manufacturing capabilities, Hataphar serves as a comprehensive B2B partner offering contract manufacturing (OEM/ODM), raw material trading, and import-export authorization services. The company manages an extensive distribution network covering all 63 provinces in Vietnam and sources high-quality raw materials from global markets, including France, Germany, Switzerland, and Japan. Its diverse portfolio includes recognized brands such as Augclamox, Zanmite, and Bosunamin, catering to both domestic and international healthcare needs.
ELEMULTI C
Elemon C
Dưỡng Tâm Đan
Oraliver Gold
TPBVSK Calcido
TPBVSK Bosugold
TPBVSK BIOXGUT
Thực phẩm bảo vệ sức khỏe Esbalanc Gold
Nước súc miệng Oslorid
Nước súc miệng Nano Silver-DHT
ICA Biotechnological & Pharmaceutical Joint Stock Company
🇻🇳 Vietnam
1999501-1000 peopleManufacturer/Distributor/Wholesaler/Service CompanyHigh capacity factory
Established brand
Own brand
High-tech enterprise
Key market
🇯🇵 Japan
Description
ICA Biotechnological & Pharmaceutical Joint Stock Company is a leading manufacturer and distributor of pharmaceutical and biotechnological products based in Thuan An, Binh Duong, Vietnam. Established in 1995 as a distribution firm, the company transitioned to manufacturing in 1999 and currently operates a large-scale production facility with a workforce of 501 to 1000 employees. The company maintains a robust quality management system with certifications including Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and Good Storage Practice (GSP).
ICA specializes in a diverse range of therapeutic areas, producing tablets, capsules, and sachets. Its extensive product portfolio includes essential medicines for cardiovascular diseases, diabetes, high cholesterol, and gastric ulcers, as well as specialized treatments such as anti-HIV medications, analgesics, and anti-inflammatory drugs. Notable proprietary and licensed brands include Tobicom (eye supplements), Adagrin (erectile dysfunction treatment), Coxlec, Fortec, and Liponil 10. Beyond human health, the company also provides veterinary preparations and health supplements.
As a vertically integrated enterprise, ICA offers OEM services and manages a comprehensive supply chain serving hospitals, pharmacies, and clinics. While maintaining a strong domestic presence in Vietnam through its Hanoi and Ho Chi Minh City offices, the company is active in international trade, exporting to Southeast Asia and Japan, with strategic expansion plans for the US market. The company is recognized for its commitment to mobilizing advanced technology and capital to support its growth as a major player in the regional pharmaceutical sector.
Caricin 500 (Clarithromycin 500 mg)
Normostat (10) (Atorvastatin 10 mg)
Caricin 250 (Clarithromycin 250mg)
Neumomicid 1.5 (Spiramycin 1.5 MIU)
Liponil (10) (Simvastatin 10 mg)
Adagrin (Sildenafil 50 mg)
Neumomicid 3.0 (Spiramycin 3.0 MIU)
Bididi (Biphenyl dimethyl dicarboxylate 25 mg)
Dudine (Ranitidine 150 mg)
Muxystine (Acetylcysteine 200 mg)
B-Nagen 200 (Nimesulide 100 mg)
B-Nagen 100 (Nimesulide 100 mg)
